EAST WINDSOR, N.J. - One lot of Mirtazapine tablets, used to treat major depressive disorder, was recalled due to a label error on its declared strength. Aurobindo ...
One lot of the depression medication called Mirtazapine has been recalled due to a labelling error. Tablets in affected lots may be twice as strong as labelled. The ...
Market Strides is a Global aggregator and publisher of Market intelligence development reports, equity reports, database directories, and economic reports. Our repository is diverse, spanning ...
Bottles labeled 7.5 mg might contain tablets at 15 mg strength, which could cause numerous problems Aurobindo Pharma USA has voluntarily recalled a lot of its depression drug Mirtazapine because the ...
Patients exposed to a higher dose than expected may be at increased risk of sedation, agitation, increased reflexes, tremor, sweating, dilated pupils, gastrointestinal distress, nausea, constipation ...
The global Mirtazapine Drug Market report 2022 recently published by ContriveDatumInsights, provides a basic overview of the industry including definitions, classifications, applications and industry ...
(WAFB) - A particular depression medication is being recalled due to a labeling error related to the dosage strength of the medicine. Aurobindo Pharma USA, Inc ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback